Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBayliss, C. D.-
dc.contributor.authorSadarangani, M.-
dc.contributor.authorHoe, J. C.-
dc.contributor.authorCallaghan, M. J.-
dc.contributor.authorJones, C.-
dc.contributor.authorMakepeace, K.-
dc.contributor.authorDaniels-Treffandier, H.-
dc.contributor.authorDeadman, M. E.-
dc.contributor.authorPollard, A. J.-
dc.contributor.authorChan, H.-
dc.contributor.authorFeavers, I.-
dc.contributor.authorvan der Ley, P.-
dc.identifier.citationPLoS One, 2012, 7 (12), p. e51045en
dc.descriptionCorrection available at published 2013-Oct-1.-
dc.description.abstractNeisseria meningitidis is a major global pathogen causing invasive disease with a mortality of 5–10%. Most disease in developed countries is caused by serogroup B infection, against which there is no universal vaccine. Opacity-associated adhesin (Opa) proteins are major meningococcal outer membrane proteins, which have shown recent promise as a potential novel vaccine. Immunisation of mice with different Opa variants elicited high levels of meningococcal-specific bactericidal antibodies, demonstrating proof in principle for this approach. Opa proteins are critical in meningococcal pathogenesis, mediating bacterial adherence to host cells, and modulating human cellular immunity via interactions with T cells and neutrophils, although there are conflicting data regarding their effects on CD4+ T cells. We constructed Opa-positive and Opa-negative meningococcal strains to allow further evaluation of Opa as a vaccine component. All four opa genes from N. meningitidis strain H44/76 were sequentially disrupted to construct all possible combinations of N. meningitidis strains deficient in one, two, three, or all four opa genes. The transformations demonstrated that homologous recombination of exogenous DNA into the meningococcal chromosome can occur with as little as 80 bp, and that minor sequence differences are permissible. Anti-Opa bactericidal antibody responses following immunisation of mice with recombinant Opa were specific to the Opa variant used in immunisation. No immunomodulatory effects were observed when Opa was contained within meningococcal outer membrane vesicles (OMVs), compared to Opa-negative OMVs. These observations support the incorporation of Opa in meningococcal vaccines.en
dc.publisherPublic Library of Scienceen
dc.rightsCopyright © 2012 Sadarangani et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.en
dc.subjectNeisseria meningitidisen
dc.subjectRecombinant proteinsen
dc.subjectPlasmid constructionen
dc.subjectHomologous recombinationen
dc.subjectMeningococcal diseaseen
dc.subjectPolymerase chain reactionen
dc.titleConstruction of Opa-Positive and Opa-Negative Strains of Neisseria meningitidis to Evaluate a Novel Meningococcal Vaccineen
dc.typeJournal Articleen
dc.description.versionPublisher Versionen
pubs.organisational-group/Organisation/COLLEGE OF MEDICINE, BIOLOGICAL SCIENCES AND PSYCHOLOGY/School of Biological Sciencesen
pubs.organisational-group/Organisation/COLLEGE OF MEDICINE, BIOLOGICAL SCIENCES AND PSYCHOLOGY/School of Biological Sciences/Department of Geneticsen
Appears in Collections:Published Articles, Dept. of Genetics

Files in This Item:
File Description SizeFormat 
journal.pone.0051045.pdfPublished (publisher PDF)492.22 kBAdobe PDFView/Open

Items in LRA are protected by copyright, with all rights reserved, unless otherwise indicated.